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Besides hyper-production of chromosomal AmpC β-lactamases, the expression of plasmid-encoded 23 
extended-spectrum β-lactamases (ESBL) in Enterobacter spp has increased in recent years. In this study, 24 
we characterized 10 clinical isolates of Enterobacter spp and 1 isolate of Pantoea agglomerans, with 25 
respect to the occurrence of ESBL- and plasmid-mediated quinolone resistance (PQMR) genes. Species 26 
identification and antimicrobial susceptibility testing were performed by the Vitek 2 system, broth 27 
microdilution, agar diffusion and Etests methods. ESBL-, PQMR- and other resistance genes were 28 
detected using PCR and sequencing. Strain typing was done by ERIC-2 PCR. The P. agglomerans and 29 
an Enterobacter cloacae isolate were found to harbour ESBL gene blaCTX-M-15, PQMR genes qnrB and 30 
aac-(6’)-Ib-cr, trimethoprim/sulfamethoxazole resistance genes dfrA14/Sul1 and tetracycline resistance 31 
genes (tet). In addition, class 1 and 2 integrons were found in these 2 isolates. The result of the ERIC-2 32 
PCR showed distinct patterns indicating heterogeneity of all 10 isolates. This report is the first 33 
description of CTX-M-15 production and the emergence of PMQR in P. agglomerans and E. cloacae 34 
isolates from Nigeria. Transfer of resistance genes by conjugation and the presence of mobile elements 35 
demonstrate the risk of further dissemination into other Enterobacteriaceae which may result in limited 36 









Resistance of Enterobacter spp. to expanded-spectrum cephalosporins is known to be mediated by the 44 
hyperproduction of chromosomal AmpC β-lactamases. However, the additional expression of a plasmid-45 
encoded extended-spectrum beta-lactamase (ESBL) has become more prevalent worldwide in recent 46 
years (Ko et al., 2008). In Nigeria, ESBL-production in Enterobacter spp has been associated with 47 
TEM- and SHV-type ESBL (Aibinu et al., 2003; Kasap et al., 2010). Other β-lactamase resistance 48 
determinants, conferring resistance to extended spectrum cephalosporins, such as blaVEB, blaOXA and 49 
blaCMY have just recently been reported in Nigerian Providencia spp strains. (Aibinu et al., 2011).  In 50 
addition, the worldwide report of the spread of CTX-M-15 (Canto´n and Coque, 2006),   has emerged in 51 
Nigeria, having being identified in only Klebsiella spp and E coli (Soge et al., 2006; Olowe et al., 2010). 52 
There is no documented report yet on ESBL-production mediated by blaCTX-M-15 or the association of the 53 
spread of plasmid-mediated quinolone resistance (PMQR) determinants in Enterobacter spp from 54 
Nigeria. This study reports the phenotypic and genotypic characteristics of 10 clinical isolates of 55 
Enterobacter spp and 1 isolate of Pantoea agglomerans with respect to the occurrence of CTX-M ESBL 56 
and other different resistance genes. The Enterobacter spp consisted of Enterobacter asburiae (n=1), 57 
Enterobacter aerogenes (n=1), Enterobacter cloacae (n=8) and one isolate of Pantoea agglomerans, 58 
representing 9.5% of all Enterobacteriaceae isolated within a period of 6 months from October 2008 to 59 
March 2009 at Lagos University Teaching Hospital (LUTH), a tertiary hospital, in Nigeria. Enterobacter 60 
agglomerans had previously been renamed Pantoea agglomerans to reflect its genetic distance from the 61 




Bacterial species identification was performed using VITEK 2 system (VITEK2 GN-card; bioMérieux, 64 
France). Antimicrobial susceptibility testing was determined according to the guidelines of the Clinical 65 
Laboratory Standards Institute (CLSI, 2010) by broth microdilution method and VITEK2 AST-N13 card. 66 
Quality control strain used was Escherichia coli ATCC 25922 (Oxoid UK). Etest strips containing 67 
cefotaxime in combination with clavulanic acid; and the double disk synergy tests (ESBL/AmpC ID 68 
D68C, Mast Group) were used for phenotypic detection and differentiation of both ESBL and AmpC-69 
production. Broth mate conjugation assays were performed as described by Pfeifer et al. (2009). 70 
Different ESBL genes (blaTEM, blaSHV, blaCTX-M), plasmid-mediated quinolone resistance (PMQR) genes 71 
(qnr, aac(6′)-Ib-cr), class 1 and 2 integron with tetracycline and trimethoprim resistance genes were 72 
detected by PCR as previously described (Ng et al., 2001; Frech et al., 2003; Boualle`gue-Godet et al., 73 
2005; Cano et al., 2009; Jin and Ling, 2009). All positive PCR products were sequenced using the ABI 74 
Prism 3100 genetic analyser (Applied Biosystems). Additionally, sequence analysis of the quinolone 75 
resistance determining region (QRDR) of genes gyrA and parC were performed (Cano et al. (2009). 76 
Epidemiological relationship between the 11 isolates was analysed by ERIC-2 PCR (Versalovic et al., 77 
1999). 78 
Phenotypical analysis of the 11 isolates of this study revealed that 2 isolates (E. cloacae 213K and P. 79 
agglomerans 69K) were ESBL-producers. The ESBL gene blaCTX-M-15 gene was identified in both 80 
isolates. Isolate P. agglomerans 69K was isolated from the blood culture of an adult male patient 81 
admitted for sepsis and diagnosed HIV type-1 positive on admission. The patient was treated empirically 82 
with ceftriaxone and was referred to another clinic for follow-up on HIV treatment.  Several weeks later, 83 
the patient was rushed back to the emergency unit of LUTH and examination showed the patient was 84 
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brought in dead. 85 
Isolate E. cloacae 213K, was recovered from the urine sample of an adult female patient attending the 86 
outpatient clinic of LUTH. She was diagnosed with a urinary tract infection and treated empirically with 87 
ceftriaxone. Two different urine cultures yielded each time, 2 isolates (E. coli and E. cloacae) with both 88 
isolate harbouring the gene blaCTX-M-15. The 2 ESBL study isolates (P. agglomerans 69K and E. cloacae 89 
213K) were multiply resistant to different antibiotics including ampicillin, cefepime, cefoxitin, 90 
aztreonam, ceftazidime, cefotaxime, gentamicin, tobramycin, levofloxacin, ciprofloxacin, tetracycline 91 
and sulfmethoxazole/trimethoprim. Both isolates harboured the class 1 and 2 integrons. The identified 92 
gene cassettes within the class 1 integrons included aminoglycoside resistance genes (aadA1, aph and 93 
aac-(6')-Ib), sulphonamide resistance genes (sul1) and the chloramphenicol resistance gene (cat1) in the 94 
P. agglomerans isolate (Table 1). The presence of the insertion sequence ISEcp1 upstream of the blaCTX-95 
M-15 gene was confirmed by PCR (Baraniak et al., 2002). Additionally, both isolates harboured the 96 
PQMR gene qnrB1 and aac-(6')-lb-cr. The tetracycline resistance gene tet(K), encoding an efflux pump, 97 
was identified in P. agglomerans 69K while E. cloacae 213K harboured tet(A) and tet(E) resistance 98 
determinants. By conjugation experiments, plasmids of >90kbp size were successfully transferred into E. 99 
coli J53 recipients. The E. coli J53 transconjugants had resistance pattern similar to that of the donor 100 
strain but remained susceptible to cefoxitin and showed MIC reduction for ciprofloxacin from 8 to 2 101 
µg/ml (69K) and from 4 to 2µg/ml (213K), respectively. The transconjugants displayed co-resistance to 102 
gentamicin with MIC of 8µg/ml for both strains and their transconjugants. PCR and sequence analysis, 103 
showed the E. coli J53 transconjugants harbored blaCTX-M-15, dfrA14, qnrB1, the aac-(6`)-Ib (encoding 104 
aminoglycoside modifying enzyme) and the aac-(6')-lb-cr variant. QRDR analysis revealed that the P. 105 
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agglomerans 69K isolate had a mutation at codon 87 but no mutation at codon 80 of the topoisomerase 106 
IV gene parC (nalidixic acid MIC= 32µg/ml). In the QRDR of the E. cloacae 213K isolate, no gyrA or 107 
parC mutation was observed (nalidixic acid MIC=32µg/ml). 108 
 The other nine Enterobacter spp isolates in the present study were susceptible to many antibiotics and 109 
were non-ESBL-producers. They all harboured the class 1 integron. The Class 2 integron was 110 
additionally found in 45% (n=4) of the isolates. Resistance to trimethoprim/sulfamethoxazole was 111 
associated with the presence of sul1 (100%) and either a dfrA1 (72.7%), or dfrA14 (54.6%) or both 112 
genes (36.4%) (Table 1). The tet(A) and tet(E) genes were the predominant tet gene occurring. The 113 
strain typing by ERIC-2 PCR revealed distinct patterns indicating heterogeneity of all Enterobacter spp 114 
isolates.  115 
We report in this study, the first description of ESBL-type CTX-M-15 in P. agglomerans and E. cloacae 116 
isolates from Nigeria. This study showed a low occurrence of Enterobacter spp in clinical infection 117 
during this study period (9.5%) and the rate of prevalence of ESBL-production was 18.2% (n=2). 118 
Unfortunately, it was not possible to determine whether the ESBL- and PMQR genes in the isolates were 119 
hospital- or community-acquired because clinical data showed no record of previous hospital admission 120 
for the patients. The result of this study furthermore suggests, that the association of CTX-M-15, PQMR 121 
determinants qnrB1, aac-(6')-lb-cr and other resistance genes in addition to mobile elements (ISEcp1, 122 
class 1 and 2 integrons) may facilitate the rapid dissemination of antimicrobial resistances into other 123 
Gram-negative bacteria in Nigeria limiting the choice of antibiotic therapy.  124 
The nucleotide sequences of resistance genes in P. agglomerans 69K have been deposited in the 125 
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and  Tetracycline 
Genes 
ESBL, PMQR, 
Integrons and  
Resistance Gene 
Cassettes 
E. aerogenes (28K) High Vaginal Swab 
(copious vaginal 
discharge) 
amp, ams, cet, cfz, 
tet 
tet(A) Class 1 integron, 
qac∆E, sul1 
E. asburiae (85K) Urine (urinary tract 
infection) 




Class 1 and 2 
integron,  qac∆E, 
sul1 




Class 1  integron,  
qac∆E, sul1 




Class 1 and 2 
integron,  qac∆E, 
sul1 




Class 1  integron,  
qac∆E, sul1 
E. cloacae (54K) Blood (sepsis) Amp, ams, cfz, sxt, 
tet 
dfrA1, tet(E) Class 1 integron, 
sul1   
E. cloacae (56K) Blood (Neonatal 
sepsis) 
Amp, ams, cfz, sxt, 
tet 
dfrA1, tet(E) Class 1 integron,  
qac∆E, sul1 
E. cloacae (59K) Catheter-tip Amp, ams, cfz, sxt, 
tet 
dfrA1,  tet(E) Class 1  integron, 
sul1 
E. cloacae (64K) Blood (Neonatal Amp, ams, cfz, sxt, dfrA1,  tet(A) Class 1 and 2 
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sepsis) tet integron,  qac∆E, 
sul1 
E. cloacae (213K) Urine (urinary tract 
infection) 
amp, ams, azt, cfz, 
fep, cet, caz,  cip, 
gen, lev, tob, sxt, 
tet, ctx, fox 
dfrA14,  tet(A), 
tet(E) 
CTX-M-15,  qnrB1, 
aac-(6’)-lb-cr,  Class 
1 and 2 integron, 




Blood (sepsis)  amp, ams, azt, cfz, 
fep, caz,  cip, gen, 
pt, tob, sxt, tet, ctx, 
fox  
dfrA14, tet(K) CTX-M-15, TEM-1,   
qnrB1, aac-(6’)-lb-
cr, Class 1 and 2 
integron, aph, 
aadA1, cat1,   
qac∆E, sul1 
Key:  amp=ampicillin, ams=ampicillin/sulbactam, azt=aztreonam, cet=cephalothin, cfz=cefazolin, fep=cefepime, 188 
caz=ceftazidime, cip=ciprofloxacin, gen=gentamicin, fox=cefoxitin, pt=piperacillin/tazobactam, tobramycin, 189 
sxt=trimethoprim/sulfamethoxazole, lev=levofloxacin, tet=tetracycline, ctx=cefotaxime 190 
